risk of pancreatitis with tirzepatide warning GLP-1 Risk: MHRA and Patient Guide Tirzepatide and Pancreatitis Risk: Safety – Researchers Describe Cases of Pancreatitis

Importantly, these effects are age dependent, with retinal degeneration becoming pronounced only after 10 months of age (51)

At 16 weeks of treatment, if you have not seen at least a 4% decrease in body weight, you should stop using Saxenda since it will unlikely lead to meaningful weight loss

Policy And if that answer is yes, then you may next start wondering about the side effects that come with these GLP-1 agonist medications

Consult your healthcare provider If hunger persists despite nutritional and lifestyle adjustments, a medical review is appropriate

It shifts the narrative away from self-blame and toward targeted, science-backed solutions

This structural property theoretically limits their ability to transfer across the blood-breast milk barrier, though individual variation in lactation composition exists